THE ANABOLICPROTOCOL
MedicationsLow risk

Lisinopril

Also known as: Zestril, Prinivil, Ramipril, Enalapril, Perindopril

The classic ACE inhibitor — effective and cheap, with kidney-protective evidence, but the dry cough drives a lot of people to an ARB instead.

Substance family

Cardiovascular & metabolic agents

Medications for blood pressure, lipids and glucose. They appear here because these are exactly the markers most anabolic compounds push in the wrong direction.

Effects on

Which outcomes this substance acts on — descriptive, not a recommendation.

Strain profile

Where this substance is most likely to hit — a rough orientation, individually dependent on dose, duration and predisposition.

Liver
minimal
Kidneys
low
Blood lipids
minimal
Hematocrit
minimal
Blood pressure
minimal
Hormonal axis
minimal

This substance works against

Dosing & protocols by goal

Rough orientation ranges as reported in harm-reduction literature — not an individual treatment plan. Doses are individual and open-ended; frequency depends on the ester or half-life.

Blood-pressure control (on cycle)

Ancillary

Dose

5–20 mg / day

Frequency

1× / day

Cycle length

While blood pressure is elevated

Start at 5 mg. Ramipril (2.5–10 mg) and enalapril (5–20 mg) belong to the same class and behave similarly; the choice between them is mostly regional habit.

Supraphysiological doses carry significant health risks and are not legal without a medical indication. This information serves education and harm reduction, not as a usage recommendation. Accompanying blood work and — where relevant — a post-cycle plan (PCT) are essential. See the disclaimer.

Side effect & countermeasure

Typical problems and what you can do to reduce harm — at a glance. Does not replace medical monitoring.

Problem

Persistent dry cough

Countermeasure

Affects roughly 5–15 % of users and is the most common reason for stopping. It is caused by bradykinin accumulation, not by an infection, and it does not respond to cough medication or to lowering the dose. The correct move is switching to an ARB such as telmisartan, which blocks the same pathway one step further down and does not cause it.

Problem

High potassium (hyperkalaemia)

Countermeasure

ACE inhibitors raise potassium. Combined with spironolactone, a potassium supplement or an ARB, the effect stacks and can reach an arrhythmia-relevant range. Dangerously high potassium is almost symptomless before the rhythm problem — a blood test is the only way to see it coming.

Problem

Angioedema — rare, but an emergency

Countermeasure

Sudden swelling of the lips, tongue or throat can occur at any point during treatment, including after months without problems. It obstructs the airway and is a call for emergency services, not a wait-and-see situation. Anyone who has had it must never take an ACE inhibitor again.

Problem

Kidney function declining on start

Countermeasure

A small creatinine rise after starting is expected and usually harmless. A large one is not, and it points to reduced kidney perfusion — particularly relevant on top of dehydration, a diuretic, high-dose NSAIDs or a heavily depleted contest prep. Check creatinine and eGFR a couple of weeks after starting.

Problem

NSAID painkillers blunt the effect

Countermeasure

Ibuprofen, diclofenac and similar drugs reduce the blood-pressure effect and increase the kidney risk of the combination. Regular painkiller use for training injuries is common enough that this interaction matters here more than in the general population.

Overview

Lisinopril stands for its whole class here: ramipril, enalapril and perindopril work the same way and the choice between them is largely a matter of what is prescribed locally. ACE inhibitors are among the best-studied drugs in medicine, with decades of outcome data behind them.

In this context they sit alongside telmisartan and amlodipine as sensible options for cycle-driven hypertension — metabolically neutral, no effect on androgens, no electrolyte depletion. Their distinguishing feature is genuine kidney-protective evidence, which matters for anyone with an already-strained kidney picture from high protein intake, dehydration or oral compounds.

Mechanism of Action

The renin-angiotensin system regulates blood pressure by converting angiotensin I into angiotensin II, a potent vasoconstrictor that also drives aldosterone release and therefore sodium and water retention. Lisinopril blocks the enzyme that performs that conversion, so vessels relax and less fluid is retained.

The same enzyme also breaks down bradykinin. Blocking it means bradykinin accumulates — which is the cause of both the characteristic dry cough and, rarely, angioedema. ARBs like telmisartan block the angiotensin receptor instead of the enzyme, leaving bradykinin alone, which is exactly why they do not cause the cough.

ACE Inhibitor or ARB?

For most people reading this, the practical answer is that either works and the ARB is the more comfortable default:

  • Cough: the deciding factor for many. If it appears, switch rather than persist.
  • Kidney protection: both classes have it; ACE inhibitors have the longer evidence base.
  • Potassium: both raise it. The interaction with spironolactone applies to both.
  • Cost and availability: ACE inhibitors are cheaper and available everywhere.

There is no reason to take both together. The combination increases the potassium and kidney risk without a corresponding benefit, and it was abandoned in medicine for that reason.

Side Effects & Risks

  • Persistent dry cough
  • High potassium
  • Angioedema — rare, potentially life-threatening
  • Dizziness and low blood pressure, especially with the first dose
  • Creatinine rise, kidney function decline in susceptible people
  • Loss of taste, rash

Blood Work & Monitoring

  • Potassium — before starting and again a few weeks in
  • Kidney function (creatinine, eGFR) — same schedule; this class shifts both
  • Sodium
  • Blood pressure — a home cuff, measured properly, sitting and standing
  • Hematocrit — often the driver behind the elevated pressure in the first place

Legal status by region

Regulation differs considerably between jurisdictions and changes over time. This is a rough orientation, not legal advice — check the rules that apply where you are.

RegionRegulatory status
United StatesPrescription-only medicineApproved for hypertension, heart failure and post-infarction care.
EU / UKPrescription-only medicineRamipril is the more commonly prescribed member of the class in much of Europe.
Canada / AustraliaPrescription-only medicine
Parts of Asia, Latin America & Middle EastPharmacy availability varies
Competitive sportNot prohibitedACE inhibitors are not on the WADA list.
All content on this page is for information and harm-reduction purposes only. It is not medical advice, not a recommendation to purchase or use, and does not replace consulting a doctor. Legal status and enforcement vary by country and change; verifying the current rules in your own jurisdiction is your responsibility. For adults 18+ only. See the full disclaimer.